Clinical Trial: Establishment of a molecular diagnostic platform for the early diagnosis and prediction of Alzheimer’s disease using tear biomarkers (China)

Posted On: 2026-09-24

China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Establishment of a molecular diagnostic platform for the early diagnosis and prediction of Alzheimer’s disease using tear biomarkers'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133253

Registration Time: 2026/09/23

Type: Diagnostic test

Primary Sponsor: Shanghai Baoshan District Dachang Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344574

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Establishment of a molecular diagnostic platform for the early diagnosis and prediction of Alzheimer’s disease using tear biomarkers (China)